Targeting Src tyrosine kinase to enhance radioiodide uptake in breast cancer.

Saved in:
Bibliographic Details
Title: Targeting Src tyrosine kinase to enhance radioiodide uptake in breast cancer.
Authors: Poole VL; Department of Metabolism & Systems Science (MSS) and Centre for Endocrinology, Diabetes and Metabolism (CEDAM), College of Medicine and Health, University of Birmingham, Birmingham, UK., Alshahrani MM; Department of Metabolism & Systems Science (MSS) and Centre for Endocrinology, Diabetes and Metabolism (CEDAM), College of Medicine and Health, University of Birmingham, Birmingham, UK., Manivannan S; Department of Metabolism & Systems Science (MSS) and Centre for Endocrinology, Diabetes and Metabolism (CEDAM), College of Medicine and Health, University of Birmingham, Birmingham, UK., Landa I; Institut Gustave Roussy, Inserm U981, Villejuif, France.; IHU-National PRecISion Medicine Center in Oncology, Villejuif, France., Hariharan A; Department of Metabolism & Systems Science (MSS) and Centre for Endocrinology, Diabetes and Metabolism (CEDAM), College of Medicine and Health, University of Birmingham, Birmingham, UK., Thompson RJ; Department of Metabolism & Systems Science (MSS) and Centre for Endocrinology, Diabetes and Metabolism (CEDAM), College of Medicine and Health, University of Birmingham, Birmingham, UK., Kocbiyik M; Department of Metabolism & Systems Science (MSS) and Centre for Endocrinology, Diabetes and Metabolism (CEDAM), College of Medicine and Health, University of Birmingham, Birmingham, UK., Thornton CEM; Department of Metabolism & Systems Science (MSS) and Centre for Endocrinology, Diabetes and Metabolism (CEDAM), College of Medicine and Health, University of Birmingham, Birmingham, UK., Brookes K; Department of Metabolism & Systems Science (MSS) and Centre for Endocrinology, Diabetes and Metabolism (CEDAM), College of Medicine and Health, University of Birmingham, Birmingham, UK., Fletcher A; Department of Metabolism & Systems Science (MSS) and Centre for Endocrinology, Diabetes and Metabolism (CEDAM), College of Medicine and Health, University of Birmingham, Birmingham, UK., Boelaert K; Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK., Read ML; Department of Metabolism & Systems Science (MSS) and Centre for Endocrinology, Diabetes and Metabolism (CEDAM), College of Medicine and Health, University of Birmingham, Birmingham, UK., McCabe CJ; Department of Metabolism & Systems Science (MSS) and Centre for Endocrinology, Diabetes and Metabolism (CEDAM), College of Medicine and Health, University of Birmingham, Birmingham, UK., Smith VE; Department of Metabolism & Systems Science (MSS) and Centre for Endocrinology, Diabetes and Metabolism (CEDAM), College of Medicine and Health, University of Birmingham, Birmingham, UK.
Source: Endocrine-related cancer [Endocr Relat Cancer] 2025 Aug 20; Vol. 32 (8). Date of Electronic Publication: 2025 Aug 20 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: BioScientifica Country of Publication: England NLM ID: 9436481 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1479-6821 (Electronic) Linking ISSN: 13510088 NLM ISO Abbreviation: Endocr Relat Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1479-6821
DOI:10.1530/ERC-24-0312